Granata Bio
Duxbury, US · Founded 2020 · Delaware corporation · 2 known investors
Biopharma platform developing and commercializing IVF medication
Biotechin /granatabio
Founders & leadership
ES
EVAN SUSSMANExecutive Officer, Director
SF
SARAH FARANDAExecutive Officer, Director
DP
DAVID PALLERExecutive Officer, Director
EH
EDUARDO HARITONDirector
PT
PETER TUREKDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$13.8MraisedDec 2024 · 3 investors · BiotechnologyRule 506(b)
▶$13.8MraisedDec 2024 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- EVAN SUSSMANExecutive Officer, Director
- SARAH FARANDAExecutive Officer, Director
- EDUARDO HARITONDirector
- DAVID PALLERExecutive Officer, Director
- PETER TUREKDirector
- Offering amount
- $15M
- Amount sold
- $13.8M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$10.1MraisedNov 2023 · 10 investors · BiotechnologyRule 506(b)
▶$10.1MraisedNov 2023 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- SARAH FARANDAExecutive Officer, Director
- EVAN SUSSMANExecutive Officer, Director
- EDUARDO HARITONDirector
- DAVID PALLERExecutive Officer, Director
- Offering amount
- $14M
- Amount sold
- $10.1M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.